These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND Ki-67 AND Prognosis
145 results:

  • 1. Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.
    Wang Y; Xing H; Guo X; Chen W; Wang Y; Liang T; Wang H; Li Y; Jin S; Shi Y; Liu D; Yang T; Xia Y; Li J; Wu J; Liu Q; Qu T; Guo S; Li H; Zhang K; Wang Y; Ma W
    Cancer Med; 2024 Jul; 13(13):e7369. PubMed ID: 38970209
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis.
    Shi Y; Kang X; Ge Y; Cao Y; Li Y; Guo X; Chen W; Guo S; Wang Y; Liu D; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Feng F; Wang Y; You H; Ma W
    BMC Neurol; 2024 Jun; 24(1):202. PubMed ID: 38877400
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
    Xi S; Huang Q; Zeng J
    J Neuropathol Exp Neurol; 2024 Jan; 83(2):125-130. PubMed ID: 38175671
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.
    Peng Y; Ren Y; Huang B; Tang J; Jv Y; Mao Q; Liu Y; Lei Y; Zhang Y
    Sci Rep; 2023 Jun; 13(1):9970. PubMed ID: 37340065
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.
    Jiang H; Zhu Q; Wang X; Li M; Shen S; Yang C; Zhao X; Li M; Ma G; Zhao X; Chen X; Yang J; Lin S
    Cancer Sci; 2023 Sep; 114(9):3708-3718. PubMed ID: 37332121
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low expression of ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
    Tini P; Yavoroska M; Mazzei MA; Miracco C; Pirtoli L; Tomaciello M; Marampon F; Minniti G
    J Neurooncol; 2023 Jun; 163(2):339-344. PubMed ID: 37227648
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prediction of ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
    Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  

  • 11. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An integrative non-invasive malignant brain tumors classification and ki-67 labeling index prediction pipeline with radiomics approach.
    Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
    Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush.
    Li S; Guo F; Wang X; Zeng J; Hong J
    Clin Transl Oncol; 2022 Nov; 24(11):2146-2154. PubMed ID: 35753023
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma.
    Higa N; Akahane T; Hamada T; Yonezawa H; Uchida H; Makino R; Watanabe S; Takajo T; Yokoyama S; Kirishima M; Matsuo K; Fujio S; Hanaya R; Tanimoto A; Yoshimoto K
    Cancer Med; 2023 Jan; 12(1):49-60. PubMed ID: 35695190
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Monocentric evaluation of ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
    Dumke R; Dumke C; Eberle F; Nimsky C; Keber U; Engenhart-Cabillic R; Lautenschläger S
    Strahlenther Onkol; 2022 Oct; 198(10):892-906. PubMed ID: 35612598
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Anaplastic pleomorphic xanthoastrocytoma - single-center analysis of 42 patients].
    Belyaev AY; Shugai SV; Kobyakov GL; Strunina YV; Batalov AI; Pronin IN; Usachev DY
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(2):45-54. PubMed ID: 35412712
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic and histopathological associations with outcome in pediatric pilocytic astrocytoma.
    Cler SJ; Skidmore A; Yahanda AT; Mackey K; Rubin JB; Cluster A; Perkins S; Gauvain K; King AA; Limbrick DD; McEvoy S; Park TS; Smyth MD; Mian AY; Chicoine MR; Dahiya S; Strahle JM
    J Neurosurg Pediatr; 2022 May; 29(5):504-512. PubMed ID: 35148515
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysis.
    Sommerlath VN; Buergy D; Etminan N; Brehmer S; Reuss D; Sarria GR; Guiot MC; Hänggi D; Wenz F; Petrecca K; Giordano FA
    Radiat Oncol; 2022 Jan; 17(1):15. PubMed ID: 35073955
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiologic-pathologic association of tumor-like lesions with inflammation in cerebral white matter: Comparison of two cases with distinct clinical outcomes.
    Shishido-Hara Y; Akazawa K; Takeuchi H; Hirato J; Konishi E; Yamada K; Itoh K; Hashimoto N
    Neuropathology; 2021 Dec; 41(6):468-475. PubMed ID: 34791710
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 8.